Shopping Cart
- Remove All
- Your shopping cart is currently empty
Socazolimab (ZKAB001), an anti-PD-L1 monoclonal antibody, demonstrates enduring safety and efficacy in treating recurrent or metastatic cervical cancer. Additionally, it shows promise for treating small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma, and osteosarcoma [1] [2] [3] [4] [5].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $198 | 7-10 days | |
5 mg | $538 | 7-10 days | |
10 mg | $859 | 7-10 days | |
25 mg | $1,270 | 7-10 days | |
50 mg | $1,720 | 7-10 days |
Description | Socazolimab (ZKAB001), an anti-PD-L1 monoclonal antibody, demonstrates enduring safety and efficacy in treating recurrent or metastatic cervical cancer. Additionally, it shows promise for treating small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma, and osteosarcoma [1] [2] [3] [4] [5]. |
Cas No. | 2305043-30-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.